Holen Sie sich die Stockscreener-App
14.36
4.46%
-0.67
Handel nachbörslich:
14.36
Surgery Partners Inc Aktie (SGRY) Neueste Nachrichten
Does Surgery Partners’ (SGRY) Slower M&A Pace Clarify or Complicate Its ASC-Focused Strategy? - simplywall.st
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call - Yahoo Finance
Surgery Partners (SGRY) Reaffirmed Guidance On Revenue Growth, Is It Still A Bargain? - Sahm
Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY) - Yahoo Finance
Surgery Partners Inc. (SGRY) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
King Street Capital discloses 4.6% Surgery Partners (SGRY) holding in Schedule 13G - Stock Titan
Why (SGRY) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Surgery Partners Inc (1SP.DU) Recent Insider Transactions - Yahoo! Finance Canada
TD Cowen Initiates Surgery Partners(SGRY.US) With Buy Rating, Announces Target Price $19 - Moomoo
Surgery Partners (NASDAQ:SGRY) Downgraded by Zacks Research to Hold - MarketBeat
Surgery Partners (SGRY) Stock Drops As Idaho Falls Sale Reshapes Debt Story - Sahm
Surgery Partners Inc (1SP.DU) insider ownership and holdings - Yahoo Finance UK
Is Surgery Partners Inc (SGRY) a Bargain After 5.8% Drop? GF Val - GuruFocus
Surgery Partners beats Q2 revenue and EPS estimates, with strong growth and positive outlook. - Pluang
SGRY Maintained by TD Cowen -- Price Target Raised to $19.00 - GuruFocus
Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight By Investing.com - Investing.com Nigeria
SGRY Maintained by RBC Capital -- Price Target Lowered to $19.00 - GuruFocus
Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight - Investing.com
Benchmark reiterates Buy rating on Surgery Partners stock at $24 By Investing.com - Investing.com South Africa
Benchmark reiterates Buy rating on Surgery Partners stock at $24 - Investing.com
SGRY Reiterated by Cantor Fitzgerald -- Price Target Maintained at $18 - GuruFocus
Surgery Partners (NASDAQ:SGRY) Given Overweight Rating at Cantor Fitzgerald - MarketBeat
Surgery Partners (SGRY) Q2 Earnings: What To Expect - Yahoo Finance
RBC Capital Adjusts Price Target on Surgery Partners to $19 From $20, Keeps Outperform Rating - marketscreener.com
Surgery Partners, Inc. (SGRY) Investor Outlook: Navigating a 16.84% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Surgery Partners Q2 2026 slides show 5% revenue growth, Idaho exit - Investing.com Canada
SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift - The Globe and Mail
Surgery Partners, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:SGRY) 2026-08-10 - seekingalpha.com
Why Surgery Partners (NASDAQ:SGRY) Draws Healthcare Attention Monday? - Kalkine Media
Surgery Partners (NASDAQ: SGRY) posts Q2 2026 loss and plans $795M hospital sale - Stock Titan
Surgery Partners Crushes Q2 2026 Profit Estimates by 66.7% - AlphaStreet
Surgery Partners: Q2 Earnings Snapshot - AOL.com
Surgery Partners Releases Q2 2026 Financial Results - AlphaStreet
SGRY Looks 42.7% Undervalued on GF Value™ Despite Profit Challen - GuruFocus
Earnings call transcript: Surgery Partners misses Q2 2026 EPS, revenue beats - Investing.com Nigeria
Surgery Partners Q2 Earnings Call Highlights - MarketBeat
Surgery Partners (NASDAQ:SGRY) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Surgery Partners shares edge lower despite Q2 revenue beat - Yahoo Finance
Surgery Partners Announces Q2 and H1 2026 Financial Results with Investor Call - Kalkine Media
Surgery Partners Inc earnings missed by $0.18, revenue topped estimates - Investing.com Canada
Transcript : Surgery Partners, Inc., Q2 2026 Earnings Call, Aug 10, 2026 - marketscreener.com
Surgery Partners, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Surgery Partners beats revenue but misses on earnings By Investing.com - Investing.com Canada
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Surgery Partners' Q2 Earnings Decline, Revenue Rises - marketscreener.com
Is Surgery Partners Inc (SGRY) a Value Trap? Q2 EPS at -$0.15 on $848.9 Million Revenue; GF Score: 57/100 - GuruFocus
Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript - The Globe and Mail
SGRY Looks 42.1% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
Surgery Partners beats revenue but misses on earnings - Investing.com
Surgery Partners (NASDAQ:SGRY) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
Surgery Partners Reports Second Quarter 2026 Results, Reaffirms Full-Year Outlook - Quiver Quantitative
Earnings Flash (SGRY) Surgery Partners Posts Q2 Adjusted EPS $0.10, vs. FactSet Est of $0.06 - marketscreener.com
Earnings Flash (SGRY) Surgery Partners, Inc. Reports Q2 Revenue $848.9M, vs. FactSet Est of $830.0M - marketscreener.com
Surgery Partners Q2 revenue beats on growth in same-facility segment - TradingView
1.05%
1.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):